指南与共识呼吸危重症与机械通气慢阻肺

成人急性呼吸衰竭无创呼吸支持:美国胸科学会临床实践指南

Noninvasive respiratory support for adult patients with acute respiratory failure: an official American Thoracic Society Clinical Practice Guideline.
指南 / 共识 · Am J Respir Crit Care Med · 2026-01-01

该指南由美国胸科学会制定,采用GRADE方法,基于系统综述和网状Meta分析,针对成人急性低氧性和高碳酸血症性呼吸衰竭、插管前预氧合及拔管后呼吸支持四个PICO问题给出推荐。核心推荐包括:急性低氧性呼吸衰竭强烈推荐经鼻高流量氧疗(HFNC),条件推荐无创通气(NIV)或持续气道正压(CPAP);急性高碳酸血症性呼吸衰竭强烈推荐NIV以降低死亡率和插管需求;插管前预氧合强烈推荐HFNC或NIV;拔管后根据风险选择HFNC或NIV。

要点

  • 急性低氧性呼吸衰竭:强烈推荐HFNC,条件推荐NIV或CPAP,需密切监测升级支持需求。
  • 急性高碳酸血症性呼吸衰竭:强烈推荐NIV降低死亡率和插管需求;轻症(pH>7.25)可条件推荐HFNC。
  • 插管前预氧合强烈推荐HFNC或NIV;拔管后低风险用HFNC、高风险用NIV以减少再插管。

核心结论

  • 无创呼吸支持策略可改善多种临床场景的结局,推荐需结合患者风险、机构能力和接口耐受性。

研究设计与样本

  • 多学科专家组采用GRADE方法,基于系统综述和网状Meta分析,针对四个PICO问题制定推荐。

主要发现

  • 急性低氧性呼吸衰竭:强烈推荐HFNC,条件推荐NIV或CPAP,主要基于对插管需求的影响。
  • 急性高碳酸血症性呼吸衰竭:强烈推荐NIV以降低死亡率和有创机械通气需求。
  • 对较轻高碳酸血症且轻度酸血症(如pH>7.25)患者,条件推荐HFNC,需密切监测并随时升级至NIV。
  • 插管前预氧合:强烈推荐HFNC或NIV以预防围插管期低氧血症。
  • 拔管后:基于风险推荐低风险患者用HFNC、高风险患者用NIV以减少再插管。

关键数值与推荐

  • 急性低氧性呼吸衰竭:强烈推荐HFNC;条件推荐NIV或CPAP。
  • 急性高碳酸血症性呼吸衰竭:强烈推荐NIV;条件推荐HFNC仅用于较轻高碳酸血症且pH>7.25的患者。
  • 插管前预氧合:强烈推荐HFNC或NIV。
  • 拔管后:低风险患者建议HFNC,高风险患者建议NIV。

临床怎么用

  • 急性低氧性呼吸衰竭优先考虑HFNC,NIV或CPAP可作为条件选择,均需密切监测插管指征。
  • 急性高碳酸血症性呼吸衰竭首选NIV;轻症(pH>7.25)可考虑HFNC但需具备快速升级至NIV的条件。
  • 插管前预氧合选用HFNC或NIV;拔管后根据再插管风险选择HFNC(低风险)或NIV(高风险)。

局限性

  • 推荐需进一步结合患者风险、机构能力和接口耐受性进行个体化调整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute hypoxemic and hypercapnic respiratory failure are among the most common reasons for ICU admission and need for invasive mechanical ventilation. Noninvasive respiratory support (NIRS) strategies-including high-flow nasal cannula (HFNC), noninvasive ventilation (NIV), and continuous positive airway pressure (CPAP)-may prevent intubation, improve outcomes, and reduce ICU utilization. However, there is uncertainty regarding optimal patient and modality selection, resulting in variable implementation. There are no clinical practice guidelines comprehensively addressing the use of the different NIRS strategies across the spectrum of acute respiratory failure. OBJECTIVE: To update and develop new evidence-based clinical practice recommendations informing NIRS use, including HFNC, NIV and CPAP, in adults with acute respiratory failure. METHODS: A multidisciplinary panel used the Grading of Recommendations, Assessment, Development, and Evaluation approach to address four PICO (Population, Intervention, Comparator, Outcome) questions related to the use of NIRS for hypoxemic and hypercapnic respiratory failure, preoxygenation for intubation, and postextubation respiratory support. Recommendations were informed by several systematic reviews and network meta-analyses. RESULTS: The panel made a strong recommendation for HFNC and a conditional recommendation for NIV or CPAP for adults with acute hypoxemic respiratory failure with close monitoring for the need for escalation of respiratory support, based primarily on effects on need for intubation. For acute hypercapnic respiratory failure, the panel made a strong recommendation for NIV to reduce mortality and need for invasive mechanical ventilation, and a conditional recommendation for HFNC only in patients with less severe hypercapnia and with mild acidemia (eg, pH > 7.25), provided that close monitoring and prompt escalation to NIV are available. The panel made a strong recommendation for HFNC or NIV for preoxygenation prior to endotracheal intubation to prevent peri-intubation hypoxemia. The panel also issued a risk-based recommendation, suggesting HFNC for low-risk patients and NIV for high-risk patients to reduce the need for re-intubation following extubation after critical illness. CONCLUSIONS: Noninvasive respiratory support strategies are effective in improving outcomes in a range of clinical scenarios. We provide evidence-based recommendations, which can be further informed by patient risk, institutional capacity, and interface tolerance.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Goel NN, Ferreyro BL, Pitre T, et al. Noninvasive respiratory support for adult patients with acute respiratory failure: an official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2026. PMID: 42371750. doi:10.1093/ajrccm/aamag302

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。